{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:39:17Z","timestamp":1793194757996,"version":"4.5.0"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:00:00Z","timestamp":1684972800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004541","name":"Ministry of Education, India","doi-asserted-by":"publisher","award":["NRF-2020R1I1A2066868"],"award-info":[{"award-number":["NRF-2020R1I1A2066868"]}],"id":[{"id":"10.13039\/501100004541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014343","name":"National Tea Research Foundation","doi-asserted-by":"publisher","award":["NRF-2021R1C1C2014229"],"award-info":[{"award-number":["NRF-2021R1C1C2014229"]}],"id":[{"id":"10.13039\/501100014343","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HF20C0038"],"award-info":[{"award-number":["HF20C0038"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["2022-IT-RD-0205\\u201301-101"],"award-info":[{"award-number":["2022-IT-RD-0205\\u201301-101"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["2020R1A5A2019413"],"award-info":[{"award-number":["2020R1A5A2019413"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.biopha.2023.114938","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T21:28:25Z","timestamp":1685568505000},"page":"114938","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Review deciphering potent therapeutic approaches targeting Notch signaling pathway in breast cancer"],"prefix":"10.1016","volume":"164","author":[{"given":"Pratibha","family":"Pandey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3449-7978","authenticated-orcid":false,"given":"Fahad","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujeet Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han Na","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moon Nyeo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong-Gyu","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev Kumar","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupa","family":"Mazumder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonglee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2023.114938_bib1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/978-1-4614-0899-4_18","article-title":"Notch signaling and breast cancer","author":"Reedijk","year":"2012","journal-title":"Notch Signal. Embryol. Cancer"},{"key":"10.1016\/j.biopha.2023.114938_bib2","first-page":"2019","article-title":"Notch signaling activation as a hallmark for triple-negative breast cancer subtype","author":"Giuli","year":"2019","journal-title":"J. Oncol."},{"issue":"3","key":"10.1016\/j.biopha.2023.114938_bib3","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10911-021-09496-1","article-title":"Mammary development and breast cancer: a notch perspective","volume":"26","author":"Chen","year":"2021","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"issue":"21\u201322","key":"10.1016\/j.biopha.2023.114938_bib4","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1101\/gad.342287.120","article-title":"The many facets of Notch signaling in breast cancer: toward overcoming therapeutic resistance","volume":"34","author":"Nandi","year":"2020","journal-title":"Genes Dev."},{"issue":"12","key":"10.1016\/j.biopha.2023.114938_bib5","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3390\/genes10120961","article-title":"A \u201cNOTCH\u201d deeper into the epithelial-to-mesenchymal transition (EMT) program in breast cancer","volume":"10","author":"Kar","year":"2019","journal-title":"Genes"},{"key":"10.1016\/j.biopha.2023.114938_bib6","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3389\/fendo.2019.00573","article-title":"Pathways to endocrine therapy resistance in breast cancer","volume":"10","author":"Haque","year":"2019","journal-title":"Front. Endocrinol."},{"issue":"3","key":"10.1016\/j.biopha.2023.114938_bib7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10911-021-09496-1","article-title":"Mammary development and breast cancer: a notch perspective","volume":"26","author":"Chen","year":"2021","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"issue":"24_Supplement","key":"10.1016\/j.biopha.2023.114938_bib8","doi-asserted-by":"crossref","first-page":"P6","DOI":"10.1158\/0008-5472.SABCS10-P6-15-03","article-title":"Abstract P6-15-03: phase Ib trial of the gamma secretase inhibitor (GSI), MK-0752 followed by docetaxel in locally advanced or metastatic breast cancer","volume":"70","author":"Schott","year":"2010","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2023.114938_bib9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1158\/1078-0432.CCR-14-0607","article-title":"A phase I, dose-finding study in patients with advanced solid malignancies of the oral \u03b3-secretase inhibitor PF-03084014\u03b3-secretase inhibitor PF-03084014 evaluation in solid tumors","volume":"21","author":"Messersmith","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.biopha.2023.114938_bib10","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1158\/0008-5472.CAN-05-3054","article-title":"Aberrant activation of notch signaling in human breast cancer","volume":"66","author":"Stylianou","year":"2006","journal-title":"Cancer Res."},{"issue":"24_Supplement","key":"10.1016\/j.biopha.2023.114938_bib11","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1158\/0008-5472.SABCS11-S1-5","article-title":"S1-5: modulation of cancer and stem cell biomarkers by the notch inhibitor MK-0752 added to endocrine therapy for early stage ER+ breast cancer","volume":"71","author":"Albain","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2023.114938_bib12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jsbmb.2014.12.013","article-title":"HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44+\/CD24\u2212\/low tumor-initiating subpopulation in basal-like breast cancer","volume":"148","author":"So","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.biopha.2023.114938_bib13","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3389\/fonc.2018.00518","article-title":"Moving breast cancer therapy up a notch","volume":"8","author":"Mollen","year":"2018","journal-title":"Front Oncol."},{"issue":"21\u201322","key":"10.1016\/j.biopha.2023.114938_bib14","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1101\/gad.342287.120","article-title":"The many facets of Notch signaling in breast cancer: toward overcoming therapeutic resistance","volume":"34","author":"Nandi","year":"2020","journal-title":"Genes Dev."},{"issue":"2","key":"10.1016\/j.biopha.2023.114938_bib15","doi-asserted-by":"crossref","first-page":"e298","DOI":"10.1002\/onco.13595","article-title":"More insights on the use of \u03b3\u2010secretase inhibitors in cancer treatment","volume":"26","author":"L\u00f3pez\u2010Nieva","year":"2021","journal-title":"Oncologist"},{"key":"10.1016\/j.biopha.2023.114938_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.119007","article-title":"\u03b3-Secretase inhibitors for breast cancer and hepatocellular carcinoma: from mechanism to treatment","volume":"268","author":"Jia","year":"2021","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.biopha.2023.114938_bib17","first-page":"2743","article-title":"Notch and breast cancer metastasis: current knowledge, new sights and targeted therapy","volume":"18","author":"Zhang","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.biopha.2023.114938_bib18","first-page":"1","article-title":"Protein nanoparticles as natural drugs carriers for cancer therapy","author":"Zaher","year":"2022","journal-title":"Adv. Tradit. Med."},{"key":"10.1016\/j.biopha.2023.114938_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s13596-021-00566-7","article-title":"A comprehensive review on phytochemistry, bioactivity and medicinal value of bioactive compounds of pomegranate (Punica granatum)","volume":"23","author":"Ranjha","year":"2023","journal-title":"Adv. Tradit. Med."},{"issue":"7","key":"10.1016\/j.biopha.2023.114938_bib20","doi-asserted-by":"crossref","first-page":"5913","DOI":"10.1002\/jcb.26783","article-title":"Significance of Notch and Wnt signaling for chemoresistance of colorectal cancer cells HCT116","volume":"119","author":"Kukcinaviciute","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.biopha.2023.114938_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-018-0925-x","article-title":"HIF-2\u03b1 promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways","volume":"37","author":"Yan","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.biopha.2023.114938_bib22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000478703","article-title":"Targeting developmental pathways: the achilles heel of cancer?","volume":"93","author":"Dempke","year":"2017","journal-title":"Oncology"},{"issue":"2","key":"10.1016\/j.biopha.2023.114938_bib23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.20892\/j.issn.2095-3941.2016.0032","article-title":"Developmental pathways associated with cancer metastasis: Notch, Wnt, and Hedgehog","volume":"14","author":"Kamdje","year":"2017","journal-title":"Cancer Biol. Med."},{"issue":"11","key":"10.1016\/j.biopha.2023.114938_bib24","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/s41419-018-1083-y","article-title":"Positive feedback loop between mitochondrial fission and Notch signaling promotes survivin-mediated survival of TNBC cells","volume":"9","author":"Chen","year":"2018","journal-title":"Cell death Dis."},{"issue":"4","key":"10.1016\/j.biopha.2023.114938_bib25","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0092-8674(87)90123-1","article-title":"Mutations altering the structure of epidermal growth factor-like coding sequences at the Drosophila Notch locus","volume":"51","author":"Kelley","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2023.114938_bib26","first-page":"341","article-title":"Notch in mammary gland development and breast cancer","volume":"vol. 14","author":"Politi","year":"2004"},{"key":"10.1016\/j.biopha.2023.114938_bib27","first-page":"2019","article-title":"Notch signaling activation as a hallmark for triple-negative breast cancer subtype","author":"Giuli","year":"2019","journal-title":"J. Oncol."},{"issue":"24","key":"10.1016\/j.biopha.2023.114938_bib28","doi-asserted-by":"crossref","first-page":"6209","DOI":"10.3390\/cancers13246209","article-title":"The role of breast cancer stem cells in chemoresistance and metastasis in triple-negative breast cancer","volume":"13","author":"He","year":"2021","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.biopha.2023.114938_bib29","first-page":"914","article-title":"ADAM17 promotes lymph node metastasis in gastric cancer via activation of the Notch and Wnt signaling pathways","volume":"43","author":"Li","year":"2019","journal-title":"Int. J. Mol. Med."},{"issue":"5","key":"10.1016\/j.biopha.2023.114938_bib30","doi-asserted-by":"crossref","first-page":"979","DOI":"10.2741\/4844","article-title":"EMT in breast cancer metastasis: an interplay of microRNAs, signaling pathways and circulating tumor cells","volume":"25","author":"Kumar","year":"2020","journal-title":"Front. Biosci. -Landmark"},{"key":"10.1016\/j.biopha.2023.114938_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12032-021-01610-x","article-title":"Molecular targets and therapeutics in chemoresistance of triple-negative breast cancer","volume":"39","author":"Nath","year":"2022","journal-title":"Med. Oncol."},{"key":"10.1016\/j.biopha.2023.114938_bib32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10549-009-0621-9","article-title":"Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancer","volume":"123","author":"Cohen","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"issue":"2","key":"10.1016\/j.biopha.2023.114938_bib33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.arcmed.2019.12.019","article-title":"Highly expressed DLL4 and JAG1: their role in incidence of breast cancer metastasis","volume":"51","author":"Zohny","year":"2020","journal-title":"Arch. Med. Res."},{"issue":"3","key":"10.1016\/j.biopha.2023.114938_bib34","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.3892\/ol.2017.5609","article-title":"Current status of the prognostic molecular biomarkers in breast cancer: A systematic review","volume":"13","author":"Kutomi","year":"2017","journal-title":"Oncol. Lett."},{"issue":"4","key":"10.1016\/j.biopha.2023.114938_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19336918.2015.1129481","article-title":"The tumor microenvironment: an irreplaceable element of tumor budding and epithelial-mesenchymal transition-mediated cancer metastasis","volume":"10","author":"Li","year":"2016","journal-title":"Cell Adhes. Migr."},{"issue":"11","key":"10.1016\/j.biopha.2023.114938_bib36","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.biopha.2023.114938_bib37","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10585-021-10102-1","article-title":"Cancer cell metabolic plasticity in migration and metastasis","volume":"38","author":"Mosier","year":"2021","journal-title":"Clin. Exp. Metastas."},{"key":"10.1016\/j.biopha.2023.114938_bib38","doi-asserted-by":"crossref","DOI":"10.1017\/erm.2021.13","article-title":"Tumour microenvironment: a non-negligible driver for epithelial\u2212 mesenchymal transition in colorectal cancer","volume":"23","author":"Han","year":"2021","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.biopha.2023.114938_bib39","doi-asserted-by":"crossref","DOI":"10.1177\/15330338221118984","article-title":"Expressions and prognostic values of Notch3 and DLL4 in human breast cancer","volume":"22","author":"Wang","year":"2023","journal-title":"Technol. Cancer Res. Treat."},{"issue":"10","key":"10.1016\/j.biopha.2023.114938_bib40","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3390\/cancers10100346","article-title":"The \u201cYin and Yang\u201d of natural compounds in anticancer therapy of triple-negative breast cancers","volume":"10","author":"Varghese","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2023.114938_bib41","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.3389\/fimmu.2018.01230","article-title":"A review of notch processing with new insights into ligand-independent notch signaling in T-cells","volume":"9","author":"Steinbuck","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2023.114938_bib42","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s12015-007-0023-5","article-title":"Mammary stem cells and breast cancer\u2014role of Notch signalling","volume":"3","author":"Farnie","year":"2007","journal-title":"Stem Cell Rev."},{"key":"10.1016\/j.biopha.2023.114938_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109200","article-title":"3-O-(E)-p-Coumaroyl betulinic acid possess anticancer activity and inhibit Notch signaling pathway in breast cancer cells and mammosphere","volume":"328","author":"Kushwaha","year":"2020","journal-title":"Chem. - Biol. Interact."},{"key":"10.1016\/j.biopha.2023.114938_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116783","article-title":"Bulbine frutescens phytochemical inhibits notch signaling pathway and induces apoptosis in triple negative and luminal breast cancer cells","volume":"234","author":"Kushwaha","year":"2019","journal-title":"Life Sci."},{"issue":"14_Supplement","key":"10.1016\/j.biopha.2023.114938_bib45","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2016-4632","article-title":"Effects of Hsp90 inhibitors on triple-negative breast cancer: BRCA1 as a therapeutic target for TNBC","volume":"76","author":"Ramamoorthy","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2023.114938_bib46","first-page":"2022","article-title":"N-((1-(4-fluorophenyl)-1H-1, 2, 3-triazol-4-yl) methyl)-2-methylene-3-oxo-olean-12-en-28-amide induces apoptosis in human breast cancer cells by stimulating oxidative stress and inhibiting the Notch-Akt signaling pathway","author":"Li","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"4","key":"10.1016\/j.biopha.2023.114938_bib47","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.jsps.2017.04.037","article-title":"Oridonin inhibits breast cancer growth and metastasis through blocking the Notch signaling","volume":"25","author":"Xia","year":"2017","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.biopha.2023.114938_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105686","article-title":"Cimigenoside functions as a novel \u03b3-secretase inhibitor and inhibits the proliferation or metastasis of human breast cancer cells by \u03b3-secretase\/Notch axis","volume":"169","author":"Jia","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"9","key":"10.1016\/j.biopha.2023.114938_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137614","article-title":"6-Shogaol inhibits breast cancer cells and stem cell-like spheroids by modulation of Notch signaling pathway and induction of autophagic cell death","volume":"10","author":"Ray","year":"2015","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.biopha.2023.114938_bib50","first-page":"908","article-title":"Inhibition of breast cancer cell survival by Xanthohumol via modulation of the Notch signaling pathway in vivo and in vitro","volume":"15","author":"Sun","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.biopha.2023.114938_bib51","article-title":"Total flavonoids of Litchi seed attenuate stem cell-like properties in breast cancer by regulating Notch3 signaling pathway","author":"Liao","year":"2023","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2023.114938_bib52","first-page":"351","article-title":"Bioinformatics and in vitro studies reveal the importance of p53, PPARG and notch signaling pathway in inhibition of breast cancer stem cells by hesperetin","volume":"11","author":"Hermawan","year":"2021","journal-title":"Adv. Pharm. Bull."},{"issue":"5","key":"10.1016\/j.biopha.2023.114938_bib53","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1159\/000438535","article-title":"Luteolin inhibits breast cancer development and progression in vitro and in vivo by suppressing notch signaling and regulating MiRNAs","volume":"37","author":"Sun","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.biopha.2023.114938_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116783","article-title":"Bulbine frutescens phytochemical inhibits notch signaling pathway and induces apoptosis in triple negative and luminal breast cancer cells","volume":"234","author":"Kushwaha","year":"2019","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.biopha.2023.114938_bib55","first-page":"1","article-title":"3, 6-dihydroxyflavone suppresses the epithelial-mesenchymal transition in breast cancer cells by inhibiting the Notch signaling pathway","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2023.114938_bib56","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1124\/jpet.113.207563","article-title":"Silibinin induces cell death through reactive oxygen species\u2013dependent downregulation of notch-1\/ERK\/Akt signaling in human breast cancer cells","volume":"349","author":"Kim","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2023.114938_bib57","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.rvsc.2020.07.017","article-title":"Effects of Notch signaling components from breast cancer cells treated in culture with resveratrol","volume":"132","author":"Dong","year":"2020","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.biopha.2023.114938_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110302","article-title":"6-Shogaol suppresses the growth of breast cancer cells by inducing apoptosis and suppressing autophagy via targeting notch signaling pathway","volume":"128","author":"Bawadood","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"17","key":"10.1016\/j.biopha.2023.114938_bib59","doi-asserted-by":"crossref","first-page":"6733","DOI":"10.1074\/jbc.RA119.007671","article-title":"A novel triazole, NMK-T-057, induces autophagic cell death in breast cancer cells by inhibiting \u03b3-secretase\u2013mediated activation of Notch signaling","volume":"294","author":"Das","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2023.114938_bib60","first-page":"676","article-title":"Rhamnetin induces apoptosis in human breast cancer cells via the miR 34a\/Notch 1 signaling pathway","volume":"17","author":"Lan","year":"2019","journal-title":"Oncol. Lett."},{"issue":"3","key":"10.1016\/j.biopha.2023.114938_bib61","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/cas.12880","article-title":"Novel combination of serum microRNA for detecting breast cancer in the early stage","volume":"107","author":"Shimomura","year":"2016","journal-title":"Cancer Sci."},{"issue":"3","key":"10.1016\/j.biopha.2023.114938_bib62","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: towards a new era for the management of cancer and other diseases","volume":"16","author":"Rupaimoole","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2023.114938_bib63","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s12094-015-1303-1","article-title":"Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features","volume":"17","author":"Zuberi","year":"2015","journal-title":"Clin. Transl. Oncol."},{"issue":"13","key":"10.1016\/j.biopha.2023.114938_bib64","doi-asserted-by":"crossref","first-page":"16923","DOI":"10.18632\/oncotarget.7850","article-title":"Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer","volume":"7","author":"Meng","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.biopha.2023.114938_bib65","first-page":"1453","article-title":"miR 200b and miR 200c co contribute to the cisplatin sensitivity of ovarian cancer cells by targeting DNA methyltransferases","volume":"17","author":"Liu","year":"2019","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.biopha.2023.114938_bib66","first-page":"1","article-title":"Tissue miR-200c-3p and circulating miR-1290 as potential prognostic biomarkers for colorectal cancer","volume":"12","author":"Kang","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2023.114938_bib67","unstructured":"Wong, G.L. (2019). Investigating a genome-wide role for endogenous siRNAs in mRNA quality control in Caenorhabditis elegans. Villanova University."},{"issue":"2","key":"10.1016\/j.biopha.2023.114938_bib68","doi-asserted-by":"crossref","first-page":"48","DOI":"10.59566\/IJBS.2017.13048","article-title":"Molecular mechanisms and biological functions of siRNA","volume":"13","author":"Dana","year":"2017","journal-title":"Int. J. Biomed. Sci.: IJBS"},{"key":"10.1016\/j.biopha.2023.114938_bib69","unstructured":"RSK2, NCAPD2, and Gpx1 all function as promising therapeutic targets for the therapy of TNBC."},{"key":"10.1016\/j.biopha.2023.114938_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2019.12.005","article-title":"Exosome-mediated siRNA delivery to suppress postoperative breast cancer metastasis","volume":"318","author":"Zhao","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2023.114938_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215781","article-title":"Exosomes deliver lncRNA DARS-AS1 siRNA to inhibit chronic unpredictable mild stress-induced TNBC metastasis","volume":"543","author":"Liu","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2023.114938_bib72","article-title":"Fabrication of aptamer-guided siRNA loaded lipopolyplexes for gene silencing of notch 1 in MDA-mb-231 triple negative breast cancer cell line","volume":"65","author":"Gharaibeh","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"15","key":"10.1016\/j.biopha.2023.114938_bib73","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.3390\/ijms20153696","article-title":"Downregulation of STAT3, \u03b2-catenin, and notch-1 by single and combinations of siRNA treatment enhance chemosensitivity of wild type and doxorubicin resistant MCF-7 breast cancer cells to doxorubicin","volume":"20","author":"Alshaer","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2023.114938_bib74","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s10020-022-00480-x","article-title":"NDR1 increases NOTCH1 signaling activity by impairing Fbw7 mediated NICD degradation to enhance breast cancer stem cell properties","volume":"28","author":"Wang","year":"2022","journal-title":"Mol. Med."},{"issue":"9","key":"10.1016\/j.biopha.2023.114938_bib75","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1016\/j.apsb.2021.06.003","article-title":"Combination therapy with miR34a and doxorubicin synergistically inhibits Dox-resistant breast cancer progression via down-regulation of Snail through suppressing Notch\/NF-\u03baB and RAS\/RAF\/MEK\/ERK signaling pathway","volume":"11","author":"Yang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.biopha.2023.114938_bib76","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1080\/21655979.2021.1951929","article-title":"Circular RNA FAT atypical cadherin 1 (circFAT1)\/microRNA-525-5p\/spindle and kinetochore-associated complex subunit 1 (SKA1) axis regulates oxaliplatin resistance in breast cancer by activating the notch and Wnt signaling pathway","volume":"12","author":"Yao","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.biopha.2023.114938_bib77","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.omtn.2020.06.003","article-title":"Dual regulation of miR-34a and Notch signaling in triple-negative breast cancer by antibody\/miRNA nanocarriers","volume":"21","author":"Valcourt","year":"2020","journal-title":"Mol. Ther. -Nucleic Acids"},{"key":"10.1016\/j.biopha.2023.114938_bib78","series-title":"Targeted Nanomedicine for Breast Cancer Therapy","first-page":"281","article-title":"Nanomedicine for targeting breast cancer stem cells","author":"Bhavana","year":"2022"},{"issue":"1","key":"10.1016\/j.biopha.2023.114938_bib79","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/17425247.2016.1208650","article-title":"Nanoparticles for imaging and treatment of metastatic breast cancer","volume":"14","author":"Mu","year":"2017","journal-title":"Expert Opin. Drug Deliv."},{"issue":"13","key":"10.1016\/j.biopha.2023.114938_bib80","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2174\/1389201020666190731130001","article-title":"A review on targeting nanoparticles for breast cancer","volume":"20","author":"Alqaraghuli","year":"2019","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.biopha.2023.114938_bib81","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.biopha.2016.07.058","article-title":"The potential of photodynamic therapy (PDT)\u2014Experimental investigations and clinical use","volume":"83","author":"Oniszczuk","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2023.114938_bib82","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.2147\/IJN.S111594","article-title":"Quantum dot-based immunofluorescent imaging and quantitative detection of TOP2A and prognostic value in triple-negative breast cancer","volume":"11","author":"Zheng","year":"2016","journal-title":"Int. J. Nanomed."},{"issue":"6","key":"10.1016\/j.biopha.2023.114938_bib83","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.3390\/ijerph17062078","article-title":"Triple-negative breast cancer: a review of conventional and advanced therapeutic strategies","volume":"17","author":"Medina","year":"2020","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.biopha.2023.114938_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101734","article-title":"CRISPR\/Cas9-based genome editing for multimodal synergistic cancer nanotherapy","volume":"48","author":"Pu","year":"2023","journal-title":"Nano Today"},{"issue":"8","key":"10.1016\/j.biopha.2023.114938_bib85","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2174\/1389200221666200610173724","article-title":"Gold nanoparticles; potential nanotheranostic agent in breast cancer: a comprehensive review with systematic search strategy","volume":"21","author":"Khandker","year":"2020","journal-title":"Curr. Drug Metab."},{"issue":"6","key":"10.1016\/j.biopha.2023.114938_bib86","first-page":"797","article-title":"Targeted nanoparticles for image\u2010guided treatment of triple\u2010negative breast cancer: clinical significance and technological advances","volume":"7","author":"Miller\u2010Kleinhenz","year":"2015","journal-title":"Wiley Interdisciplinary Rev.: Nanomed. Nanobiotechnol."},{"issue":"7","key":"10.1016\/j.biopha.2023.114938_bib87","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1021\/am100237p","article-title":"High-frequency, magnetic-field-responsive drug release from magnetic nanoparticle\/organic hybrid based on hyperthermic effect","volume":"2","author":"Hayashi","year":"2010","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biopha.2023.114938_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2019.01.020","article-title":"Preparation of multifunctional Janus nanoparticles on the basis of SPIONs as targeted drug delivery system","volume":"559","author":"Shaghaghi","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2023.114938_bib89","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1039\/C9BM01171D","article-title":"CD44 targeted redox-triggered self-assembly with magnetic enhanced EPR effects for effective amplification of gambogic acid to treat triple-negative breast cancer","volume":"8","author":"Sang","year":"2020","journal-title":"Biomater. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2023.114938_bib90","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1080\/10408398.2020.1843133","article-title":"A comprehensive review on the nanocomposites loaded with chitosan nanoparticles for food packaging","volume":"62","author":"Garavand","year":"2022","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"3","key":"10.1016\/j.biopha.2023.114938_bib91","doi-asserted-by":"crossref","first-page":"eaax3931","DOI":"10.1126\/sciadv.aax3931","article-title":"Decreased nonspecific adhesivity, receptor-targeted therapeutic nanoparticles for primary and metastatic breast cancer","volume":"6","author":"Dancy","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biopha.2023.114938_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118637","article-title":"Hyaluronic acid-coated pH sensitive poly (\u03b2-amino ester) nanoparticles for co-delivery of embelin and TRAIL plasmid for triple negative breast cancer treatment","volume":"573","author":"Xu","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.biopha.2023.114938_bib93","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1021\/acsnano.9b09263","article-title":"Nanoparticle-mediated co-delivery of Notch-1 antibodies and ABT-737 as a potent treatment strategy for triple-negative breast cancer","volume":"14","author":"Valcourt","year":"2020","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.biopha.2023.114938_bib94","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1080\/21655979.2021.1951929","article-title":"Circular RNA FAT atypical cadherin 1 (circFAT1)\/microRNA-525-5p\/spindle and kinetochore-associated complex subunit 1 (SKA1) axis regulates oxaliplatin resistance in breast cancer by activating the notch and Wnt signaling pathway","volume":"12","author":"Yao","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.biopha.2023.114938_bib95","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.omtn.2020.06.003","article-title":"Dual regulation of miR-34a and Notch signaling in triple-negative breast cancer by antibody\/miRNA nanocarriers","volume":"21","author":"Valcourt","year":"2020","journal-title":"Mol. Ther. -Nucleic Acids"},{"issue":"3","key":"10.1016\/j.biopha.2023.114938_bib96","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.bbrc.2019.01.101","article-title":"MAML1 regulates EMT markers expression through NOTCH-independent pathway in breast cancer cell line MCF-7","volume":"510","author":"Razavi","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222300728X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222300728X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:28:01Z","timestamp":1793194081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222300728X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":96,"alternative-id":["S075333222300728X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114938","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Review deciphering potent therapeutic approaches targeting Notch signaling pathway in breast cancer","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114938","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114938"}}